- Scrip Originals
Brought to you by
Zai Lab signs agreement with GSK for two anti-inflammatory assets
22 Sep 2017
GlaxoSmithKline PLC licensed Zai Lab Ltd. global rights to two anti-inflammatory candidates.
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com